MBaggott
Bluelighter
- Joined
- Feb 16, 2015
- Messages
- 45
Hi, I'm Matthew Baggott, a neuroscientist who studies MDMA-like drugs and how they can be made safer, more effective, and more accessible. I'm also CEO of Tactogen, a public benefit corporation developing novel MDMA-like medicines.
I've put together an anonymous questionnaire to gather information on 5-MAPB and how it compares to MDMA. If you've used both drugs alone (i.e., without taking other substances at the same time), I'd love for you to fill out this questionnaire (link) .
The questionnaire is under 75 questions long and may take 25 minutes to complete.
The basic goal is to collect information on the human effects of 5-MAPB, which is poorly studied. I'm particularly interested in documenting whether 5-MAPB shares the therapeutic potential of MDMA.
The survey will be open for about 3 months or until it receives 200 responses, whichever comes first.
This project was examined and declared exempt from the need for approval by the Western IRB.
If you have any questions or comments, I can be reached here or via the email on the first screen of the questionnaire. Thanks!
Click here for questionnaire.
I've put together an anonymous questionnaire to gather information on 5-MAPB and how it compares to MDMA. If you've used both drugs alone (i.e., without taking other substances at the same time), I'd love for you to fill out this questionnaire (link) .
The questionnaire is under 75 questions long and may take 25 minutes to complete.
The basic goal is to collect information on the human effects of 5-MAPB, which is poorly studied. I'm particularly interested in documenting whether 5-MAPB shares the therapeutic potential of MDMA.
The survey will be open for about 3 months or until it receives 200 responses, whichever comes first.
This project was examined and declared exempt from the need for approval by the Western IRB.
If you have any questions or comments, I can be reached here or via the email on the first screen of the questionnaire. Thanks!
Click here for questionnaire.